tradingkey.logo

BUZZ-Moderna falls as Morgan Stanley cuts PT

ReutersJan 15, 2025 11:47 AM

Shares of vaccine maker Moderna MRNA.O fall 1.2% to $34.04 premarket

Brokerage Morgan Stanley lowers PT on MRNA to $38 from $70; maintains "equal-weight" rating

New PT represents a 10.3% upside to the stock's last close

On Monday, MRNA cut its 2025 sales forecast by $1 bln, hurt by slow adoption of its respiratory syncytial virus (RSV) shot and weak demand for COVID-19 vaccines

Brokerage says investors will focus on whether MRNA can achieve its 2028 "breakeven target" or if it may need to raise more equity

Brokerage notes MRNA's pipeline execution, with INT program with Merck MRK.N being a "significant opportunity" and Cytomegalovirus (CMV) vaccine a "near-term focus"

MRNA fell 63.1% in 2024

(Reporting by Kamal Choudhury in Bengaluru)

((Kamal.Choudhury@thomsonreuters.com;))

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI